Open-label safety and effectiveness of escitalopram in pediatric depression

被引：0
|
作者：
Wagner, KD [1 ]
机构：
[1] Univ Texas, Med Branch, Dallas, TX USA
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2004年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S168 / S168
页数：1
相关论文
共 50 条
  • [1] Clinical effectiveness and safety of escitalopram and desvenlafaxine in patients of depression with anxiety: A randomized, open-label controlled trial
    Maity, Nabakumar
    Ghosal, Malay Kumar
    Gupta, Anupam
    Sil, Amrita
    Chakraborty, Sushmita
    Chatterjee, Suparna
    [J]. INDIAN JOURNAL OF PHARMACOLOGY, 2014, 46 (04) : 433 - 437
  • [2] An open-label trial of escitalopram in atypical depression
    Nelson, EB
    McElroy, SL
    Strakowski, SM
    Stanford, K
    Keck, PE
    [J]. NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S158 - S159
  • [3] Escitalopram for perimenopausal depression: An open-label pilot study
    Freeman, Marlene P.
    Hill, Rebecca
    Brumbach, Barbara H.
    [J]. JOURNAL OF WOMENS HEALTH, 2006, 15 (07) : 857 - 861
  • [4] An Open-Label Safety and Pharmacokinetics Study of Duloxetine in Pediatric Patients with Major Depression
    Prakash, Apurva
    Lobo, Evelyn
    Kratochvil, Christopher J.
    Tamura, Roy N.
    Pangallo, Beth A.
    Bullok, Kristin E.
    Quinlan, Tonya
    Emslie, Graham J.
    March, John S.
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2012, 22 (01) : 48 - 55
  • [5] Escitalopram: An open-label study of bereavement-related depression and grief
    Hensley, Paula L.
    Slonimski, Carol K.
    Uhlenhuth, E. H.
    Clayton, Paula J.
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2009, 113 (1-2) : 142 - 149
  • [6] Comparative efficacy and safety of escitalopram versus desvenlafaxine in postmenopausal women with depression and anxiety: A randomized, open-label, comparative trial
    Mahajan, Sonia Shinde
    Tandon, Vishal R.
    Arora, Manu
    Mahajan, Annil
    Kotwal, Suman
    [J]. JOURNAL OF MID-LIFE HEALTH, 2019, 10 (03) : 141 - 146
  • [7] An open-label study of Escitalopram (Lexapro®) for the treatment of 'Depression of Alzheimer's disease' (dAD)
    Rao, V
    Spiro, JR
    Rosenberg, PB
    Lee, HB
    Rosenblatt, A
    Lyketsos, CG
    [J]. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2006, 21 (03) : 273 - 274
  • [8] An open-label trial of escitalopram in pervasive developmental disorders
    Owley, T
    Walton, L
    Salt, J
    Guter, SJ
    Winnega, M
    Leventhal, BL
    Cook, EH
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2005, 44 (04): : 343 - 348
  • [9] An open-label trial of escitalopram in the treatment of pathological gambling
    Black, Donald W.
    Shaw, Martha
    Forbush, Kelsie T.
    Allen, Jeff
    [J]. CLINICAL NEUROPHARMACOLOGY, 2007, 30 (04) : 206 - 212
  • [10] An open-label study of escitalopram in body dysmorphic disorder
    Phillips, KA
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2006, 21 (03) : 177 - 179
12345